HIV Rev uses a conserved cellular protein export pathway for the nucleocytoplasmic transport of viral RNAs

Current Biology

Volumn 6, Issue 7, 1996, Pages 848-854

  Fritz, Christian C ^a   Green, Michael R ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MAMMALIA; NES;

EID: 0030198504     PISSN: 09609822     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-9822(02)00608-5     Document Type: Article

References (41)

1. Sweet DJ, Gerace L: Taking from the cytoplasm and giving to the pore: soluble transport factors in nuclear protein import. Trends Cell Biol 1995, 5:444-447.
2. Moore MS, Blobel G: AG protein involved in nucleocytoplasmic transport: the role of Ran. Trends Biochem Sci 1994, 19:211-216.
3. Görlich D, Mattaj IW: Nucleocytoplasmic transport. Science 1996, 271:1513-1518.
4. Izaurralde E, Mattaj IW: RNA export. Cell 1995, 81:153-159.
5. Cullen BR: Mechanism of action of regulatory proteins encoded by complex retroviruses. Microbiol Rev 56:375-394.
6. Green MR: Molecular mechanisms of Tat and Rev. AIDS Res Rev 3:41-55.
7. Fischer U, Huber J, Boelens WC, Mattaj IW, Lührmann R: The HIV-1 Rev activation domain is a nuclear export signal that accesses an export pathway used by specific cellular RNAs. Cell 1995, 82:475-483.
8. Fritz CC, Zapp ML, Green MR: A human nucleoporin-like protein that specifically interacts with HIV Rev. Nature 1995, 367:530-533.
9. Bogerd HP, Fridell RA, Madore S, Cullen BR: Identification of a novel cellular cofactor for the Rev/ Rex class of retroviral regulatory proteins. Cell 1995, 82:485-494.
10. Wen W, Meinkoth JL, Tsien RY, Taylor SS: Identification of a signal for rapid export of proteins from the nucleus. Cell 1995, 82:463-473.
11. Hope TJ, Bond BL, McDonald D, Klein NP, Parslow TG: Effector domains of Human Immunodeficiency Virus type 1 Rev and Human T-cell Leukemia Virus type I Rex are functionally interchangeable and share an essential peptide motif. J Virol 1991, 65:6001-6007.
12. Weichselbraun I, Farrington GK, Rusche JR, Böhnlein E, Hauber J: Definition of the Human Immunodeficiency Virus type 1 Rev and Human T-cell Leukemia Virus type I Rex protein activation domain by functional exchange. J Virol 1992, 66:2583-2587.
13. Malim MH, McCarn DF, Tiley LS, Cullen BR: Mutational definition of the Human Immunodeficiency Virus Type 1 Rev activation domain. J Virol 1991, 65:4248-4254.
14. Hope TJ, Huang X, McDonald D, Parslow TG: Steroid-receptor fusion of the human immunodeficiency virus type 1 Rev transactivator: mapping cryptic functions of the arginine-rich motif. Proc Natl Acad Sci USA 1990, 87:7787-7791.
15. Rout MP, Wente SR: Pores for thought: nuclear pore complex proteins. Trends Cell Biol 1994, 4:357-365.
16. Stutz F, Neville M, Rosbash M: Identification of a novel nuclear pore-associated protein as a functional target of the HIV-1 Rev protein in yeast. Cell 1995, 82:495-506.
17. Sukegawa J, Blobel G: A nuclear pore complex protein that contains zinc finger motifs, binds DNA, and faces the nucleoplasm. Cell 1993, 72:29-38.
18. Radu A, Moore MS, Blobel G: The peptide repeat domain of nucleoporin Nup98 functions as a docking site in transport across the nuclear pore complex. Cell 1995, 81:215-222.
19. Hallberg E, Wozniak RW, Blobel G: An integral membrane protein of the pore membrane domain of the nuclear envelope contains a nucleoporin-like region. J Cell Biol 1993, 122:513-522.
20. Kraemer DM, Strambio-de-Castillia C, Blobel G, Rout MP: The essential yeast nucleoporin NUP159 is located on the cytoplasmic side of the nuclear pore complex and serves in karyopherin-mediated binding of transport substrate. J Biol Chem 1995, 270:19017-19021.
21. Kraemer DM, Wozniak RW, Blobel G, Radu A: The human CAN protein, a putative oncogene product associated with myeloid leukemogenesis, is a nuclear pore complex protein that faces the cytoplasm. Proc Natl Acad Sci USA 1994, 91:1519-1523.
22. Stutz F, Rosbash M: A functional interaction between Rev and yeast pre-mRNA is related to splicing complex formation. EMBO J 1994, 13:4096-4104.
23. Wen W, Taylor SS, Meinkoth JL: The expression and intracellular distribution of the heat-stable protein kinase inhibitor is cell cycle regulated. J Biol Chem 1995, 270:2041-2046.
24. Whitehouse S, Walsh DA,: Mg ATP-dependent interaction of the inhibitor protein of the cAMP-dependent protein kinase with the catalytic subunit. J Biol Chem 1983, 258:3682-3692.
25. Wen W, Harootunian AT, Adams SR, Feramisco J, Tsien RY, Meinkoth JL, Taylor SS: Heat-stable inhibitors of cAMP-dependent protein kinase carry a nuclear export signal. J Biol Chem 1994, 269:32214-32220.
26. Zabel U, Henkel T, Silva MdS, Baeuerle PA: Nuclear uptake control of NF-κB by MAD-3, an IκB protein present in the nucleus. EMBO J 1993, 12:201-211.
27. Cressman DE, Taub R: IκB can localise in the nucleus but shows no direct transactivation potential. Oncogene 1993, 8:2567-2573.
28. Zabel U, Baeuerle PA: Purified human IkB can rapidly dissociate the complex of the NF-κB transcription factor with its cognate DNA. Cell 1990, 61:255-265.
29. Sun SC, Ganchi PA Ballard DW, Greene WC: NF-κB controls expression of inhibitor IκB: evidence for an inducible autoregulatory pathway. Science 1993, 259:1912-1915.
30. Arenzana-Seisdedos F, Thompson J, Rodriguez MS, Bachelerie F, Thomas D, Hay RT: Inducible nuclear expression of newly synthesized IκBa negatively regulates DNA-binding and transcriptional activities of NF-κB. Mol Cell Biol 1995, 15:2689-2696.
31. Sen R, Baltimore D: Inducibility of κ immunoglobulin enhancerbinding protein NF-κB by a posttranslational mechanism. Cell 1986, 47:921-928.
32. Beg AA, Sha WC, Bronson RT, Baltimore D: Constitutive NF-κB activation, enhanced granulopoiesis, and neonatal lethality in IκBα-deficient mice. Genes Dev 1995, 9:2736-2746.
33. Wu BY, Woffendin C, Duckett CS, Ohno T, Nabel GJ: Regulation of human retroviral latency by the NF-κB/ IκB family: inhibition of human immunodeficiency virus replication by IκB through a Revdependent mechanism. Proc Natl Acad Sci USA 1995, 92:1480-1484.
34. Radu A, Blobel G, Moore MS: Identification of a protein complex that is required for nuclear protein import and mediated docking of import substrate to distinct nucleoporins. Proc Natl Acad Sci USA 1995, 92:1769-1773.
35. Rexach M, Blobel G: Protein import into nuclei: association and dissociation reactions involving transport substrate, transport factors, and nucleoporins. Cell 1995, 83:683-692.
36. Gyuris J, Golemis E, Chertkov H, Brent R: Cdi1, a human G1 and S phase phosphatase that associates with Cdk2. Cell 1993, 75:791-803.
37. Lindern MvL, Fornerod M, Baal Sv, Jaegle M, Wit Td, Buijs A, Grosveld G: The translocation (6;9), associated with a specific subtype of acute myeloid leukemia, result in the fusion of two genes, dek and can, and the expression of a chimeric, leukemia-specific dek-can mRNA. Mol Cell Biol 1992, 12:1687-1697.
38. Martin KJ, Lillie JW, Green MR: Transcriptional activation by the pseudorabies virus immediate early protein. Genes Dev 1990, 4:2367-2382.
39. Gietz D, Jean AS, Woods RA, Schiestl RH: Improved method for high efficiency transformation of intact yeast cells. Nucleic Acids Res 1992, 20:14-25.
40. Kaiser C, Michaelis S, Mitchell A: Methods in Yeast Genetics, 1994 edn. NewYork: Cold Spring Harbor Laboratory Press; 1994
41. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K: Current protocols in Molecular Biology, John Wiley & Sons; 1995.